Botulinum toxin in the treatment of neuralgia and neuropathic pain
DOI:
https://doi.org/10.12775/JEHS.2021.11.09.038Keywords
botulinum toxin, neuropathic pain, pain treatment, neuralgia, BoNT/AAbstract
Introduction: Botulinum toxin is one of the most powerful neurotoxins currently known, with high affinity to the cholinergic synapse, which sufficiently inhibits the release of acetylcholine. Its use has proved to be effective in the treatment of many diseases of the musculoskeletal system. Although most of the therapeutic effects of botulinum toxin are due to the temporary relaxation of skeletal muscles (caused by inhibition of acetylcholine release), research is ongoing into its effects on the nervous system.
Purpose of the work: The aim of the study is to analyze the effectiveness of botulinum toxin in the treatment of neuralgia and neuropathic pain.
Method: The relevant samples were accessed by means of an electronic search in the PubMed database. The analysis used reviews and meta-analyzes posted on the platform over the last 10 years.
Conclusions: Botulinum toxin has great potential in the treatment of pain. It is multitasking due to its favorable safety profile and long-lasting relief from a single injection compared to other pain medications. The side effects caused by it were assessed to be mild to moderate and included a local skin reaction (swelling), injection site pain, muscle weakness, flu symptoms, nausea and vomiting.
Keywords: botulinum toxin; neuropathic pain; pain treatment; neuralgia; BoNT / A
References
Park J, Chung ME. Botulinum Toxin for Central Neuropathic Pain. Toxins (Basel). 2018 Jun 1; 10 (6): 224. doi: 10.3390 / toxins10060224. PMID: 29857568; PMCID: PMC6024683.
Kumar R. Therapeutic use of botulinum toxin in pain treatment. Neuronal Signal. 2018 Aug 31; 2 (3): NS20180058. doi: 10.1042 / NS20180058. PMID: 32714587; PMCID: PMC7373233.
Sandrini G, De Icco R, Tassorelli C, Smania N, Tamburin S. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia. J Headache Pain. 2017 Dec; 18 (1): 38. doi: 10.1186 / s10194-017-0744-z. Epub 2017 Mar 21. PMID: 28324318; PMCID: PMC5360746.
Egeo G, Fofi L, Barbanti P. Botulinum Neurotoxin for the Treatment of Neuropathic Pain. Front Neurol. 2020 Aug 11; 11: 716. doi: 10.3389 / fneur.2020.00716. PMID: 32849195; PMCID: PMC7431775.
Rubis A, Juodzbalys G. The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review. J Oral Maxillofac Res. 2020 Jun 30; 11 (2): e2. doi: 10.5037 / jomr.2020.11202. PMID: 32760475; PMCID: PMC7393930.
Morra ME, Elgebaly A, Elmaraezy A, Khalil AM, Altibi AM, Vu TL, Mostafa MR, Huy NT, Hirayama K. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2016 Dec; 17 (1): 63. doi: 10.1186 / s10194-016-0651-8. Epub 2016 Jul 5. PMID: 27377706; PMCID: PMC4932020.
Wei J, Zhu X, Yang G, Shen J, Xie P, Zuo X, Xia L, Han Q, Zhao Y. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials. Brain Behav. 2019 Oct; 9 (10): e01409. doi: 10.1002 / brb3.1409. Epub 2019 Sep 21. PMID: 31541518; PMCID: PMC6790324.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 470
Number of citations: 0